Symbiomics
PrivateLast Round
Grant
Oct 23, 2025
Total Funding Raised
$2.84M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Symbiomics is a biotechnology company that develops high-performance biological products for agriculture to enhance crop productivity and sustainability.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiomics Comparables
Compare Symbiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Puna Bio | 79% | |
| Gênica Inovação Biotecnológica | 77% | |
| Floridienne | 76% | |
Symbiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2025 | ||||
| Series A | Jun 25, 2025 | ||||
| Seed | Dec 14, 2023 | ||||
| Seed | Jan 27, 2023 | ||||
| Pre Seed | Feb 1, 2022 |
Key People
Founding team and executive leadership
Symbiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baraúna Investimentos | Seed |
| MOV Investimentos | Seed, Series A |
| Arar Capital | Seed, Series A |
| Vesper | Seed, Pre Seed |
| Ecoa Capital | Seed |
| The Yield Lab Latam | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 10, representing 32% of headcount.
Symbiomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Symbiomics's valuation, stock price, and market status.